Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Boill Healthcare Holdings Limited ( (HK:1246) ) has provided an announcement.
Boill Healthcare Holdings Limited reported a sharp decline in interim revenue to HK$32.5 million for the six months ended 30 September 2024, down from HK$274.7 million a year earlier, with gross profit slipping to HK$8.3 million. The Group’s loss for the period widened to HK$28.5 million from HK$23.2 million, driven by HK$13.1 million in expected credit losses on financial guarantee contracts and a substantial increase in finance costs to HK$20.1 million, while selling, distribution, administrative and other expenses were significantly reduced. Loss attributable to owners of the company rose to HK$27.0 million, translating into a basic and diluted loss per share of HK1.99 cents, and total comprehensive loss reached HK$32.7 million, underscoring ongoing profitability and balance-sheet pressures despite cost-cutting efforts.
More about Boill Healthcare Holdings Limited
Boill Healthcare Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the healthcare and related property sectors. The Group’s activities include generating revenue from healthcare-related operations and associated property and investment activities within its portfolio.
Technical Sentiment Signal: Sell
Current Market Cap: HK$28.52M
See more insights into 1246 stock on TipRanks’ Stock Analysis page.